Found: 29
Select item for more details and to access through your institution.
Asking the right questions: investigating needs assessments and health-related quality-of-life questionnaires for use in oncology clinical practice.
- Published in:
- Supportive Care in Cancer, 2007, v. 15, n. 9, p. 1075, doi. 10.1007/s00520-007-0223-1
- By:
- Publication type:
- Article
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis.
- Published in:
- Journal of Neurosurgery: Spine, 2023, v. 39, n. 2, p. 278, doi. 10.3171/2023.3.SPINE221086
- By:
- Publication type:
- Article
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis.
- Published in:
- Current Oncology, 2022, v. 29, n. 6, p. 4342, doi. 10.3390/curroncol29060347
- By:
- Publication type:
- Article
Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30.
- Published in:
- Quality of Life Research, 2010, v. 19, n. 6, p. 837, doi. 10.1007/s11136-010-9636-2
- By:
- Publication type:
- Article
Concordance of cancer patients' function, symptoms, and supportive care needs.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Concordance of cancer patients’ function, symptoms, and supportive care needs.
- Published in:
- Quality of Life Research, 2009, v. 18, n. 8, p. 991, doi. 10.1007/s11136-009-9519-6
- By:
- Publication type:
- Article
Symptoms, supportive care needs, and function in cancer patients: how are they related?
- Published in:
- Quality of Life Research, 2008, v. 17, n. 5, p. 665, doi. 10.1007/s11136-008-9331-8
- By:
- Publication type:
- Article
Update in oncology.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 877, doi. 10.1007/s00432-022-04299-1
- By:
- Publication type:
- Article
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. 342, doi. 10.1093/oncolo/oyad335
- By:
- Publication type:
- Article
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 971, doi. 10.1093/oncolo/oyac140
- By:
- Publication type:
- Article
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 859, doi. 10.1634/theoncologist.2017-0465
- By:
- Publication type:
- Article
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 627, doi. 10.1634/theoncologist.2016-0390
- By:
- Publication type:
- Article
What Lies Within: Novel Strategies in Immunotherapy for Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 11, p. 1203, doi. 10.1634/theoncologist.2013-0171
- By:
- Publication type:
- Article
Dual Inhibition of the Epidermal Growth Factor Receptor Pathway with Cetuximab and Erlotinib: A Phase I Study in Patients with Advanced Solid Malignancies.
- Published in:
- Oncologist, 2009, v. 14, n. 2, p. 119, doi. 10.1634/theoncologist.2008-0124
- By:
- Publication type:
- Article
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nivolumab in NSCLC: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 85, doi. 10.1177/1758834014567470
- By:
- Publication type:
- Article
Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials.
- Published in:
- Cancer (0008543X), 2014, v. 120, p. 1113, doi. 10.1002/cncr.28571
- By:
- Publication type:
- Article
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.945798
- By:
- Publication type:
- Article
Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeting the Immune System in the Treatment of Non-Small-Cell Lung Cancer.
- Published in:
- Current Treatment Options in Oncology, 2013, v. 14, n. 4, p. 580, doi. 10.1007/s11864-013-0250-8
- By:
- Publication type:
- Article
"Who should receive epidermal growth factor receptor inhibitors for non-small cell lung cancer and when?".
- Published in:
- 2007
- By:
- Publication type:
- journal article
Pivotal PD-1 Treatment Helps Change Standard of Care in Lung Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 12, p. 791
- By:
- Publication type:
- Article
Using Immune Checkpoint Inhibitors in Lung Cancer... includes discussion.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 8, p. 713
- By:
- Publication type:
- Article
Non-small cell lung cancer: Adjuvant and neo-adjuvant chemotherapy.
- Published in:
- Respirology, 2007, v. 12, n. 3, p. 320, doi. 10.1111/j.1440-1843.2007.01081.x
- By:
- Publication type:
- Article
PD-1--Targeted Immunotheraphy: Recent Clinical Findings.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 10, p. 1
- By:
- Publication type:
- Article
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 1, p. 56, doi. 10.3171/2020.10.JNS201787
- By:
- Publication type:
- Article
Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 1, doi. 10.1007/s00277-021-04690-x
- By:
- Publication type:
- Article